Gefitinib treatment reverses post-surgical pro-metastatic immune changes and improves survival in a mouse model of osteosarcoma. (November 2020) - Kallis, Michelle P.; Maloney, Caroline; Symons, Marc; Steinberg, Bettie M.; Soffer, Samuel Z.